Recent News

• 03.04.2025 - World Obesity Day 2025: Recent Developments and the Road Ahead
• 02.11.2025 - Q4 2024 Medpace Holdings, Inc. Earnings Conference Call
• 02.10.2025 - Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2024 Results
• 02.03.2025 - Recognizing World Cancer Day & National Cancer Prevention Month
• 01.29.2025 - New FDA Guidance: Developing Drugs and Biological Products for Weight Reduction
• 01.29.2025 - New FDA Guidance: Developing Drugs and Biological Products for Weight Reduction
• 01.27.2025 - [Upcoming Webinar] Bridging Borders: Strategies for Successful Cross-Border Participation in Global Rare Disease Clinical Trials
• 01.27.2025 - [Upcoming Webinar] Bridging Borders: Strategies for Successful Cross-Border Participation in Global Rare Disease Clinical Trials
• 01.27.2025 - [Upcoming Webinar] Bridging Borders: Strategies for Successful Cross-Border Participation in Global Rare Disease Clinical Trials
• 01.09.2025 - Global Infectious Diseases & Vaccines Team – Clinical Operations Experts

Recent Filings

• 02.28.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.26.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.24.2025 - 144 Report of proposed sale of securities
• 02.11.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 02.10.2025 - 8-K Current report
• 02.10.2025 - EX-99.1 EX-99.1
• 01.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.03.2025 - 4 Statement of changes in beneficial ownership of securities